|
|
Article: Merck and Bristol-Myers Squibb License New AIDS Drugs to IPM for Development as Microbicides to Protect Women from HIV.
- Article from:
- PR Newswire Europe
- Article date:
- October 31, 2005
CopyrightCOPYRIGHT 2005 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
NEW YORK, October 31 /PRNewswire/ --
- New Nature study shows potential of 'entry inhibitor' compounds as HIV prevention tool
In a first-of-its-kind joint announcement, two of the world's leading pharmaceutical companies, Merck & Co., Inc. and Bristol-Myers Squibb have each announced today that they have signed separate license agreements with the International Partnership for Microbicides (IPM) to develop new antiretroviral compounds as potential microbicides to protect women from HIV. Under the two separate agreements, Merck and Bristol-Myers Squibb will each grant the non-profit group a royalty-free license to develop, manufacture and ...